Haleon PLC closed 10.34% below its 52-week high of £4.18, which the company achieved on March 4th.

As a hybrid healthcare and consumer staple stock, Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth. Room for expanding ...

Changes are afoot at Haleon. Following her departure from L’Oréal as president of the consumer products division for North America, Nathalie Gerschtein has been appointed chief executive ...

Haleon PLC closed 11.52% short of its 52-week high of £4.18, which the company reached on March 4th.

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon ...